Steering Novartis' regulatory landscape for over three and a half years, my role as Executive Director in Regulatory Policy has been pivotal in shaping strategies for clinical research and advanced medicinal products. With expertise in policy activities and strategic advising, our team has integrated digital tools in clinical research, enhancing operational efficiency in the EU.My contributions reflect a strong commitment to regulatory excellence, with a focus on patient-centered approaches and global health policy. Collaborating with trade associations and Health Authorities, we have prepared Novartis for legislative changes, ensuring compliance and forging paths for groundbreaking therapies to reach those in need.With a strong scientific background, I’ve consistently achieved success in policy shaping, filings, strategic planning, and people management. I take pride in maximizing the role of regulatory affairs and consistently exceeding objectives.I thrive in diverse cultural environments and am known for my effective negotiation skills, analytical mindset, and problem-solving abilities. My passion lies in navigating the complexities of regulatory landscapes to bring innovative therapies to market, ultimately benefiting patients worldwide.